These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11230607)

  • 1. Continuous infusion of glucagon induces severe hyponatremia and thrombocytopenia in a premature neonate.
    Belik J; Musey J; Trussell RA
    Pediatrics; 2001 Mar; 107(3):595-7. PubMed ID: 11230607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon is very unlikely to have caused hyponatremia.
    Coulthard MG; Hey EN
    Pediatrics; 2002 May; 109(5):985. PubMed ID: 11986470
    [No Abstract]   [Full Text] [Related]  

  • 3. Glucagon infusion for treatment of hypoglycemia: efficacy and safety in sick, preterm infants.
    Charsha DS; McKinley PS; Whitfield JM
    Pediatrics; 2003 Jan; 111(1):220-1. PubMed ID: 12509583
    [No Abstract]   [Full Text] [Related]  

  • 4. Glucagon for hypoglycaemia in infants small for gestational age.
    Carter PE; Lloyd DJ; Duffty P
    Arch Dis Child; 1988 Oct; 63(10):1264-6. PubMed ID: 3196055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term non-surgical therapy of severe persistent congenital hyperinsulinism with glucagon.
    Mohnike K; Blankenstein O; Pfuetzner A; Pötzsch S; Schober E; Steiner S; Hardy OT; Grimberg A; van Waarde WM
    Horm Res; 2008; 70(1):59-64. PubMed ID: 18493152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with intravenous glucagon infusions as a treatment for resistant neonatal hypoglycemia.
    Miralles RE; Lodha A; Perlman M; Moore AM
    Arch Pediatr Adolesc Med; 2002 Oct; 156(10):999-1004. PubMed ID: 12361445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproduction of features of the glucagonoma syndrome with continuous intravenous glucagon infusion as therapy for tumor-induced hypoglycemia.
    Case CC; Vassilopoulou-Sellin R
    Endocr Pract; 2003; 9(1):22-5. PubMed ID: 12917088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher C-peptide levels and glucose requirements may identify neonates with transient hyperinsulinism hypoglycemia who will benefit from diazoxide treatment.
    Davidov AS; Elkon-Tamir E; Haham A; Shefer G; Weintrob N; Oren A; Lebenthal Y; Mandel D; Eyal O
    Eur J Pediatr; 2020 Apr; 179(4):597-602. PubMed ID: 31863303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of glucagon administration in the diagnosis and treatment of patients with tumor hypoglycemia.
    Hoff AO; Vassilopoulou-Sellin R
    Cancer; 1998 Apr; 82(8):1585-92. PubMed ID: 9554538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic acidosis during continuous glucagon therapy for neonatal hypoglycemia.
    Hoban R; Tomlinson C; Chung E; Mann J
    Paediatr Child Health; 2023 Feb; 28(1):24-29. PubMed ID: 36865759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Very immature infants (< or = 30 Wk) respond to glucose infusion with incomplete suppression of glucose production.
    Sunehag A; Gustafsson J; Ewald U
    Pediatr Res; 1994 Oct; 36(4):550-5. PubMed ID: 7816531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyponatremia and theophylline in very low birthweight premature infants].
    Sann L; Cottancin G; Bourgeois J; Bory C; Baltassat P; Bethenod M
    Arch Fr Pediatr; 1982; 39(7):419-22. PubMed ID: 7149887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous subcutaneous infusion of glucagon by portable pump in non beta cell tumor hypoglycemia.
    Houlbert D; Altman JJ; Lageron A; Capeau J; Dahan R; Friedberg G; Wassef M; Poffenbarger PL; Segrestaa JM
    Diabete Metab; 1985 Apr; 11(2):125-7. PubMed ID: 4007224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous insulin infusion in hyperglycaemic extremely-low- birth-weight neonates.
    Ng SM; May JE; Emmerson AJ
    Biol Neonate; 2005; 87(4):269-72. PubMed ID: 15695923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with intramuscular glucagon for infants with early neonatal hypoglycemia.
    Smolkin T; Makhoul JS; Elias R; Farah F; Kugelman A; Dallashi M; Makhoul IR
    J Pediatr Endocrinol Metab; 2019 Sep; 32(9):1023-1026. PubMed ID: 31246578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged hyperinsulinemic hypoglycemia in a small for date preterm.
    Pezzati M; Barni S; Chiti G; Danesi G; Rubaltelli FF
    Minerva Pediatr; 2003 Feb; 55(1):79-82. PubMed ID: 12660630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful subcutaneous glucagon use for persistent hypoglycaemia in congenital hyperinsulinism.
    Neylon OM; Moran MM; Pellicano A; Nightingale M; O'Connell MA
    J Pediatr Endocrinol Metab; 2013; 26(11-12):1157-61. PubMed ID: 23813352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of neonatal hypoglycemia with continuous intravenous glucose infusion.
    Lilien LD; Grajwer LA; Pildes RS
    J Pediatr; 1977 Nov; 91(5):779-82. PubMed ID: 909019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Behavior of glycemic answer to glucagon in the premature infant in the first months of life].
    Zoratto E; Baratono S
    Minerva Pediatr; 1967 Aug; 19(31):1461-4. PubMed ID: 5629311
    [No Abstract]   [Full Text] [Related]  

  • 20. The Effect of Continuous Intravenous Glucagon on Glucose Requirements in Infants with Congenital Hyperinsulinism.
    Hawkes CP; Lado JJ; Givler S; De Leon DD
    JIMD Rep; 2019; 45():45-50. PubMed ID: 30311139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.